Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33

Beijing Cancer Hospital, Beijing

Liaoning Cancer Hospital, Shenyang

Harbin Medical University Cancer Hospital, Harbin

Zhongshan Hospital Fudan University, Shanghai

Obstetrics and Gynecology Hospital of Fudan University, Shanghai

Anhui Provincial Hospital, Hefei

Lu'an People's Hospital, Lu'an

Lu'an Hospital of Traditional Chinese Medicine, Lu'an

Qilu Hospital of Shandong University, Jinan

Tianjin Medical University Cancer Institute & Hospital, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Xiang'an Hospital of Xiamen University, Xiamen

Chongqing Cancer Hospital, Chongqing

Hunan Cancer Hospital, Changsha

Hunan Province Directly Affiliated Traditional Chinese Medicine Hospital, Zhuzhou

Zhongnan Hospital of Wuhan University, Wuhan

Henan Cancer Hospital, Zhengzhou

Anyang Cancer Hospital, Anyang

Nanyang First People's Hospital, Nanyang

The First Affiliated Hospital of Nanyang Medical College, Nanyang

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

Yuebei People's Hospital, Shaoguan

Shenzhen Hospital of Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen

Dongguan People's Hospital, Dongguan

Affiliated Tumor Hospital of Guangxi Medical University, Nanning

Liuzhou Workers Hospital, Liuzhou

The First Affiliated Hospital of Dali University, Dali

Sun Yat-sen University Cancer Center, Guangzhou